https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2010-10-28 / Blood 2011 Jan;117(2):393-402
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2010-10-28 / Blood 2011 Jan;117(2):393-4022010-10-28 00:00:002019-02-15 08:50:45Vaccination with dendritic cell/tumor fusion cells results in cellular and humoral antitumor immune responses in patients with multiple myeloma
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2010-10-28 / Expert Opin Biol Ther 2010 Dec;10(12):1637-47
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2010-10-28 / Expert Opin Biol Ther 2010 Dec;10(12):1637-472010-10-28 00:00:002019-02-15 08:40:13Personalized cancer vaccines
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2010-10-27 / Vaccine 2010 Nov;28(51):8162-8
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2010-10-27 / Vaccine 2010 Nov;28(51):8162-82010-10-27 00:00:002019-02-15 08:40:11Vaccination with dendritic cells charged with apoptotic/necrotic B16 melanoma induces the formation of subcutaneous lymphoid tissue
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2010-10-22 / BMC Cancer 2010 Oct;10:578
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2010-10-22 / BMC Cancer 2010 Oct;10:5782010-10-22 00:00:002019-02-15 08:48:06Chemokine-mediated distribution of dendritic cell subsets in renal cell carcinoma
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2010-10-20 / Cancer Immunol. Immunother. 2011 Jan;60(1):123-31
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2010-10-20 / Cancer Immunol. Immunother. 2011 Jan;60(1):123-312010-10-20 00:00:002019-02-15 08:49:23Resistance to the proapoptotic effects of interferon-gamma on melanoma cells used in patient-specific dendritic cell immunotherapy is associated with improved overall survival
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2010-10-13 / Int. J. Biol. Sci. 2010 Oct;6(7):639-48
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2010-10-13 / Int. J. Biol. Sci. 2010 Oct;6(7):639-482010-10-13 00:00:002019-02-15 08:47:47Comparative analysis of cytotoxic T lymphocyte response induced by dendritic cells loaded with hepatocellular carcinoma -derived RNA or cell lysate
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2010-10-05 / Br. J. Cancer 2010 Oct;103(9):1415-21
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2010-10-05 / Br. J. Cancer 2010 Oct;103(9):1415-212010-10-05 00:00:002019-02-15 08:46:05A pilot study on the immunogenicity of dendritic cell vaccination during adjuvant oxaliplatin/capecitabine chemotherapy in colon cancer patients
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2010-10-01 / Cytotherapy 2010 Oct;12(6):721-34
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2010-10-01 / Cytotherapy 2010 Oct;12(6):721-342010-10-01 00:00:002019-02-15 08:49:25Vaccination with autologous dendritic cells pulsed with multiple tumor antigens for treatment of patients with malignant melanoma: results from a phase I/II trial
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2010-10-01 / Cytotherapy 2010 Oct;12(6):735-42
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2010-10-01 / Cytotherapy 2010 Oct;12(6):735-422010-10-01 00:00:002019-02-15 08:40:23Induction of anti-tumor immunity by dendritic cells pulsed with an endoplasmic reticulum retrieval signal modifies heparanase epitope in mice
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2010-10-01 / Transplant. Proc. 2010 Oct;42(8):3306-8
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2010-10-01 / Transplant. Proc. 2010 Oct;42(8):3306-82010-10-01 00:00:002019-02-15 08:40:14Dendritic-cell tumor vaccines
